Vyndaqel
- Manufacturer
- Pfizer Labs Division of Pfizer Inc. | DELMAR CHEMICALS INC | Catalent Pharma Solutions, LLC | AndersonBrecon Inc. | Catalent Micron Technologies, Inc.
- Effective date
- 2016-01-13
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 3
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 01:29:27
Label at a glance#
ProductVyndaqel
Active ingredientTAFAMIDIS MEGLUMINE
Label structure2 sections
Label contents#
Full prescribing information#
Products#
Every source-derived product name is available through these pages.
- Vyndaqel
- tafamidis meglumine
- TAFAMIDIS
- GELATIN
- GLYCERIN
- SORBITOL
- TITANIUM DIOXIDE
- WATER
- MEDIUM-CHAIN TRIGLYCERIDES
- POLYETHYLENE GLYCOL 400
- SORBITAN MONOOLEATE
- POLYSORBATE 80
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 0069-8729 | 0069-8729-55 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| TAFAMIDIS MEGLUMINE | ZU7CF08A1A | ACTIB |
| GELATIN | 2G86QN327L | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| SORBITOL | 506T60A25R | IACT |
| TITANIUM DIOXIDE | 15FIX9V2JP | IACT |
| WATER | 059QF0KO0R | IACT |
| MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | IACT |
| POLYETHYLENE GLYCOL 400 | B697894SGQ | IACT |
| SORBITAN MONOOLEATE | 06XEA2VD56 | IACT |
| POLYSORBATE 80 | 6OZP39ZG8H | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| bb04e5f6-211e-4964-8d26-b0db54d4f578 | 417238d2-98dd-47b4-95c5-5c06dc3702dc | 2026-05-13 | 417238d2-98dd-47b4-95c5-5c06dc3702dc |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

